View Future GrowthADM Tronics Unlimited 과거 순이익 실적과거 기준 점검 0/6ADM Tronics Unlimited은 연평균 22.7%의 비율로 수입이 증가해 온 반면, Chemicals 산업은 연평균 4%의 비율로 감소했습니다. 매출은 연평균 0.08%의 비율로 감소했습니다.핵심 정보22.72%순이익 성장률22.72%주당순이익(EPS) 성장률Chemicals 산업 성장률12.93%매출 성장률-0.081%자기자본이익률-0.89%순이익률-0.20%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2025, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Jul 02ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/30/2025, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Jun 29ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/28/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Feb 16ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/15/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Nov 29ADM Tronics Prepares for Commercial Launch of Vet-Sonotron(R) Veterinary Therapy DeviceADM Tronics announced its upcoming commercial launch of the Vet-Sonotron, non-invasive veterinary therapy device, for non-drug treatment of pain. This advancement is poised to reduce veterinary care by offering a non-invasive effective solution for a wide range of animal health conditions. Based on unprecedented performance of the Vet-SonotRON to treat pain without the use of drugs, the Company expects robust demand in a veterinary market estimated at over $64 billion in the United States. The Vet-Sonotron will be available for sale or lease as well as on a pay-per-treatment unit metering system developed by ADMT. The Vet-SonotRON represents a significant leap forward in veterinary medicine, harnessing state-of-the-art therapeutic technology to address painful and debilitating musculoskeletal ailments in companion animals and livestock. The device employs cutting-edge, non-invasive technology to stimulate tissue repair, reduce inflammation, and alleviate pain, while reducing the need for drugs or surgery. This innovative approach not only improves the overall well-being of animals but also minimizes stress for animals and their caregivers. ADMT's' commitment to scientific rigor and technological excellence is reflected in the Vet-Sonotron's development. Testing and research have demonstrated the device's effectiveness across multiple species, making it a versatile and indispensable tool for veterinary practitioners. The ease of use and customizable treatment options of the Vet-Sonoton further enhance its appeal, ensuring that veterinarians can tailor treatments to the unique needs of each animal.공시 • Jul 01ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/30/2023, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Feb 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/14/2023, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Nov 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 11/14/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Aug 16ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/15/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Jun 30ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/29/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Feb 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/14/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Aug 17ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/16/2021, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Jun 30ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/29/2021, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Jan 20ADM Tronics Unlimited, Inc. Secures USPTO Registration for "Engineering Health"ADM Tronics Unlimited, Inc. has received Official Notice from the U.S. Patent and Trademark Office (USPTO) that its filing for protection for “Engineering Health” has been accepted, entitling the Company to use the registered trademark symbol in the U.S. for its engineering activities "in the field of Medical Devices.” This complements ADMT’s expansion of engineering development activities for its pipeline of proprietary therapeutic medical device technologies, as well as its medical device contract engineering services for customers. The USPTO registration of the Engineering Health registered service mark authorizes ADMT to use the “®” designation with the mark to identify such official registration. ADMT specializes in electronic medical device design, development and manufacturing of diagnostic and therapeutic medical technologies at its FDA-Registered Medical Device Manufacturing Facility in Northvale, NJ. ADMT has extensive experience in the development of all FDA classes of medical devices with a particular emphasis on electronic therapeutic modalities. The Company has a pipeline of several proprietary medical devices currently in various stages of development. In addition to its own medical technology developments, the Company is a one-stop source for complete design, engineering, regulatory and manufacturing services, specifically related to US and international medical device development. Its capability in bringing a medical device from the conceptual stage, through design, development and regulatory stages into production, all in-house, differentiates ADMT from firms supplying only portions of those services.공시 • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2020, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.매출 및 비용 세부 내역ADM Tronics Unlimited가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이OTCPK:ADMT 매출, 비용 및 순이익 (USD Millions)날짜매출순이익일반관리비연구개발비31 Dec 25301130 Sep 25301130 Jun 25301131 Mar 25301131 Dec 24301130 Sep 24301130 Jun 24301131 Mar 243-11131 Dec 233-11130 Sep 233-11130 Jun 23401131 Mar 23401131 Dec 224-11130 Sep 224-11130 Jun 223-12131 Mar 223-12131 Dec 213-12130 Sep 213-12130 Jun 213-11131 Mar 213-11131 Dec 20301130 Sep 20301130 Jun 20301131 Mar 20301131 Dec 19301130 Sep 19301130 Jun 19301131 Mar 19301131 Dec 18301030 Sep 18301030 Jun 18301031 Mar 18401131 Dec 17401030 Sep 17501030 Jun 17511031 Mar 17511031 Dec 16511030 Sep 16511030 Jun 16512031 Mar 16512031 Dec 15412030 Sep 15412030 Jun 153110양질의 수익: ADMT 은(는) 현재 수익성이 없습니다.이익 마진 증가: ADMT는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: ADMT는 수익성이 없지만 지난 5년 동안 연평균 22.7%의 속도로 손실을 줄였습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 ADMT의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: ADMT은 수익성이 없어 지난 해 수익 성장률을 Chemicals 업계(-1.4%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: ADMT는 현재 수익성이 없으므로 자본 수익률이 음수(-0.89%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/26 13:47종가2026/05/22 00:00수익2025/12/31연간 수익2025/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스ADM Tronics Unlimited, Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2025, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Jul 02ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/30/2025, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Jun 29ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/28/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Feb 16ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/15/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Nov 29ADM Tronics Prepares for Commercial Launch of Vet-Sonotron(R) Veterinary Therapy DeviceADM Tronics announced its upcoming commercial launch of the Vet-Sonotron, non-invasive veterinary therapy device, for non-drug treatment of pain. This advancement is poised to reduce veterinary care by offering a non-invasive effective solution for a wide range of animal health conditions. Based on unprecedented performance of the Vet-SonotRON to treat pain without the use of drugs, the Company expects robust demand in a veterinary market estimated at over $64 billion in the United States. The Vet-Sonotron will be available for sale or lease as well as on a pay-per-treatment unit metering system developed by ADMT. The Vet-SonotRON represents a significant leap forward in veterinary medicine, harnessing state-of-the-art therapeutic technology to address painful and debilitating musculoskeletal ailments in companion animals and livestock. The device employs cutting-edge, non-invasive technology to stimulate tissue repair, reduce inflammation, and alleviate pain, while reducing the need for drugs or surgery. This innovative approach not only improves the overall well-being of animals but also minimizes stress for animals and their caregivers. ADMT's' commitment to scientific rigor and technological excellence is reflected in the Vet-Sonotron's development. Testing and research have demonstrated the device's effectiveness across multiple species, making it a versatile and indispensable tool for veterinary practitioners. The ease of use and customizable treatment options of the Vet-Sonoton further enhance its appeal, ensuring that veterinarians can tailor treatments to the unique needs of each animal.
공시 • Jul 01ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/30/2023, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Feb 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/14/2023, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Nov 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 11/14/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Aug 16ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/15/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Jun 30ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/29/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Feb 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/14/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Aug 17ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/16/2021, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Jun 30ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/29/2021, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Jan 20ADM Tronics Unlimited, Inc. Secures USPTO Registration for "Engineering Health"ADM Tronics Unlimited, Inc. has received Official Notice from the U.S. Patent and Trademark Office (USPTO) that its filing for protection for “Engineering Health” has been accepted, entitling the Company to use the registered trademark symbol in the U.S. for its engineering activities "in the field of Medical Devices.” This complements ADMT’s expansion of engineering development activities for its pipeline of proprietary therapeutic medical device technologies, as well as its medical device contract engineering services for customers. The USPTO registration of the Engineering Health registered service mark authorizes ADMT to use the “®” designation with the mark to identify such official registration. ADMT specializes in electronic medical device design, development and manufacturing of diagnostic and therapeutic medical technologies at its FDA-Registered Medical Device Manufacturing Facility in Northvale, NJ. ADMT has extensive experience in the development of all FDA classes of medical devices with a particular emphasis on electronic therapeutic modalities. The Company has a pipeline of several proprietary medical devices currently in various stages of development. In addition to its own medical technology developments, the Company is a one-stop source for complete design, engineering, regulatory and manufacturing services, specifically related to US and international medical device development. Its capability in bringing a medical device from the conceptual stage, through design, development and regulatory stages into production, all in-house, differentiates ADMT from firms supplying only portions of those services.
공시 • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2020, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.